Baseline health status and setting impacted minimal clinically important differences in COPD: an exploratory study

Journal of Clinical Epidemiology

Volumn 116, Issue , 2019, Pages 49-61

  Alma, Harma ^a   de Jong, Corina ^a   Jelusic, Danijel ^b   Wittmann, Michael ^b   Schuler, Michael ^c   Kollen, Boudewijn ^a   Sanderman, Robbert ^a,d   Kocks, Janwillem ^a   Schultz, Konrad ^b   van der Molen, Thys ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Klinik Bad Reichenhall   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

Chronic obstructive pulmonary disease (COPD); Clinical COPD Questionnaire (CCQ); COPD Assessment Test (CAT); Health status; Minimal clinically important difference (MCID); St. George's Respiratory Questionnaire (SGRQ)

Indexed keywords

ADULT; AGE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; DETERIORATION; EXPLORATORY RESEARCH; FEMALE; FOLLOW UP; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MINIMAL CLINICALLY IMPORTANT DIFFERENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; AGED; GERMANY; NETHERLANDS; OBSERVATIONAL STUDY; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SPIROMETRY; TREATMENT OUTCOME;

AGED; FEMALE; GERMANY; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; MINIMAL CLINICALLY IMPORTANT DIFFERENCE; NETHERLANDS; OBSERVATIONAL STUDIES AS TOPIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; SPIROMETRY; TREATMENT OUTCOME;

EID: 85072221451     PISSN: 08954356     EISSN: 18785921     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2019.07.015     Document Type: Article

References (75)

1. Jones, PW. Health status measurement in chronic obstructive pulmonary disease. Thorax 2001; 56: 880-887.
2. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of COPD (2017 Report). 2017; available at http://www.goldcopd.org/gold-2017-global-strategy-diagnosis-Management-prevention-copd/. Accessed 9th of July 2018.
3. Guyatt, GH, Feeny, DH and Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993; 118: 622-629.
4. Westwood, M et al. Relationship between FEV1 change and patient-reported outcomes in randomised trials of inhaled bronchodilators for stable COPD: a systematic review. Respir Res 2011; 8 (12): 40.
5. Tsiligianni, I et al. Factors that influence disease-specific quality of life or health status in patients with COPD: a review and meta-analysis of Pearson correlations. Primary Care Respiratory Journal 2011; 20: 257-268.
6. Curtis, JR and Patrick, DL. The assessment of health status among patients with COPD. Eur Respir J 2003; 21: Suppl. 41, 36s-45s.
7. Jones, P et al. Beyond FEV1 in COPD: a review of patient-reported outcomes and their measurement. International Journal of COPD 2012; 7: 697-709.
8. Yoo, JY et al. Factors affecting the trajectory of health-related quality of life in COPD patients. Int J Tuberc Lung Dis 2015; 20 (6): 738-746.
9. Rubinsztajn, R et al. Exacerbations of Chronic Obstructive Pulmonary Disease and Quality of Life of Patients. Advs Exp Medicine, Biology - Neuroscience and Respiration 2016; 18: 69-74.
10. Kim, JK et al. Factors associated with exacerbation in mild-to-moderate COPD patients. International Journal of COPD 2016; 11: 1327-1333.
11. Henoch, I et al. Health-related quality of life in a nationwide cohort of patients with COPD related to other characteristics. European Clinical Respiratory Journal 2016; 3: 31459.
12. Wacker, ME et al. Assessing health-related quality of life in COPD: comparing generic and disease-specific instruments with focus on comorbidities. BMC Pulmonary Medicine 2016; 16: 70.
13. Corlateanu, A. et al. Predicting Health-Related Quality of Life in Patients with Chronic Obstructive Pulmonary Disease: The Impact of Age. Respiration 2016, 92: 229-234.
14. Sundh, J et al. Change in health status in COPD: a seven-year follow-up cohort study. npj Primary Care Respiratory Medicine 2016; 26: 16073.
15. Nagai, K et al. Differential changes in quality of life components over 5 years in chronic obstructive pulmonary disease patients. International Journal of COPD 2015; 10: 745-757.
16. Jones, PW et al. Minimal Clinically Important Differences in Pharmacological Trials. Am J Respir Crit Care Med 2014; 189 (3): 250-255.
17. Maltenfort, M. and Diaz-Ledezma, C. Statistics in Brief: Minimum Clinically Important Difference - Availability of Reliable Estimates. Clin Orthop Relat Res 2017; 475: 933-946.
18. Leopold, SS and Porcher, R. Editorial: The Minimum Clinically Important Difference - The Least We Can Do. Clin Orthop Relat Res 2017; 475: 929-932.
19. Jaeschke, R, Singer, J and Guyatt, GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989; 10: 407-415.
20. Angst, F, Aeschlimann, A and Angst, J. The minimal clinically important difference raised the significance of outcome effects above the statistical level, with methodological implications for future studies. J Clin Epidemiol 2017; 82: 128-136.
21. Terwee, CB et al. Mind the MIC: large variation among populations and methods. J Clin Epidemiol 2010; 63: 524-534.
22. Arima, H et al. Age variation in the minimum clinically important difference in SRS-22r after surgical treatment for adult spinal deformity - A single institution analysis in Japan. J Orthop Sci 2018; 23 (1): 20-25.
23. Dworkin, RH et al. Interpreting the Clinical Importance of Treatment Outcomes in Chronic Pain Clinical Trials: IMMPACT Recommendations. The Journal of Pain 2008; 9(2): 105-121.
24. Wang, YC, Hart, DL, Stratford PW and Mioduski JE. Baseline Dependency of Minimal Clinically Important Improvement. Phys Ther 2011; 91: 675-688.
25. Katz, NP, Paillard, FC and Ekman, E. Determining the clinical importance of treatment benefits for interventions for painful orthopedic conditions. Journal of Orthopedic Surgery and Research 2015; 10: 24.
26. Stucki G. et al. Interpretation of change scores in ordinal clinical scale and health status measures: the whole may not equal the sum of the parts. J Clin Epidemiol 1996; 49 (7): 711-717.
27. Beaton, DE, Boers, M and Wells, GA. Many faces of the minimal clinically important difference (MCID): a literature review and directions for future research. Curr Opin Rheumatol 2002; 14: 109-114.
28. Baker, DW et al. Understanding Changes in Health Status: Is the Floor Phenomenon Merely the Last Step of the Staircase? Med Care 1997; 35 (1): 1-15.
29. Copay, AG et al. Understanding the minimum clinically important difference: a review of concepts and methods. The Spine Journal 2007; 7: 541-546.
30. Crosby, RD, Kolotkin, RL and Williams, GR. Defining clinically meaningful change in health-related quality of life. J Clin Epidemiol 2003; 56: 395-400.
31. Hays, RD and Woolley JM. The Concept of Clinically Meaningful Difference in Health-Related Quality of Life Research. Pharmacoeconomics 2000; 18(5): 419-423.
32. Engel, L, Beaton, DE and Touma, Z. Minimal Clinially Important Difference: a Review of Outcome Measure Score Interpretation. Rheum Dis Clin N Am 2018; 44: 177-188.
33. Jones, PW et al. Interpreting patient-reported outcomes from clinical trials in COPD: a discussion. International Journal of COPD 2016; 11: 3069-3078.
34. Stratford, PW et al. Sensitivity to change of the Roland-Morris Back Pain Questionnaire: part 1. Phys Ther 1998; 78 (11): 1186-1196.
35. Schuller, W et al. The Influence of study population and definition of improvement on the smallest detectable change and the minimal important change of the neck disability index. Health Qual Life Outcomes 2004 2: 53.
36. Farrar JT et al. Clinical importance of changes in chronic pain intensity measured in an 11-point numerical pain rating scale. Pain 2001; 94 (2): 149-158.
37. de Vet, HC et al. Minimal changes in health status questionnaires: distinction between minimally detectable change and minimally important change. Health Qual Life Outcomes 2006; 4: 54.
38. de Vet, HCW et al. Minimally important change values of a measurement instrument depend more on baseline values than on the type of intervention. J Clin Epidemiol 2015; 68: 518-524.
39. de Vet, HCW et al. Minimally important change determined by a visual method integrating an anchor-based and a distribution-based approach. Quality of Life Research 2007; 16: 131-142.
40. Alma, HJ et al. Clinically relevant differences in COPD health status: systematic review and triangulation. Eur Resp J 2018; DOI: 10.1183/13993003.00412-2018.
41. Cave, AJ et al. Assessment of COPD wellness tools for use in primary care: an IPCRG initiative. Int J of COPD 2012; 7: 447-456.
42. Kocks, JWH et al. Assessing patient-reported outcomes in asthma and COPD patients: which can be recommended in clinical practice? Curr Opin Pulm Med 2017; 23.
43. Alma, HJ et al. Health status instruments for patients with COPD in pulmonary rehabilitation: defining a minimal clinically important difference. Npj PCRM 2016; 26: 16041.
44. Alma, HJ et al. Assessing health status over time: impact of recall period and anchor question on the minimal clinically important difference of copd health status tools. Health Qual Life Outcomes 2018; 16 (1): 130.
45. Kon, SS et al. Minimum clinically important difference for the COPD Assessment Test: a prospective analysis. Lancet Respir Med 2014; 2: 195-203.
46. Dodd, JW et al. The COPD assessment test (CAT): response to pulmonary rehabilitation. A multicenter, prospective study. Thorax 2011; 66: 425-429.
47. Jones, PW et al. Tests of the Responsiveness of the COPD Assessment Test Following Acute Exacerbation and Pulmonary Rehabilitation. Chest 2012; 142 (1): 134-140.
48. Smid, DE et al. Responsiveness and MCID Estimates for CAT, CCQ and HADS in Patients With COPD Undergoing Pulmonary Rehabilitation: A Prospective Analysis. JAMDA 2016; 1-6.
49. Tsiligianni IG et al. Assessing health status in COPD. A head-to-head comparison between the COPD assessment test (CAT) and the clinical COPD questionnaire (CCQ). BMC Pulm Med 2012; 12: 20.
50. Canavan, JL et al. Clinical COPD Questionnaire in patients with chronic respiratory disease. Respirology 2014; 19: 1006-1012.
51. Kocks, JWH et al. Health status measurement in COPD: the minimal clinically important difference of the clinical COPD questionnaire. Respiratory Research 2006; 7: 62.
52. Kon, SSC et al. The Clinical COPD Questionnaire: response to pulmonary rehabilitation and minimal clinically important difference. Thorax 2014; 69 (9): 793-798.
53. Osman, LM et al. Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease. Thorax 1997; 52: 67-71.
54. Jones, PW and Bosch, TK. Quality of Life Changes in COPD Patients Treated with Salmeterol. Am J Respir Crit Care Med 1997; 155: 1283-1289.
55. Jones, PW. St. George's Respiratry Questionnaire: MCID. COPD: Journal of Chronic Obstructive Pulmonary Disease 2005; 2: 75-79.
56. Schunemann, HJ et al. Evaluation of the minimal important difference for the feeling thermometer and the St. George's Respiratory Questionnaire in patients with chronic airflow obstruction. J Clin Epidemiol 2003; 56: 1170-1176.
57. Welling, JBA et al. The minimal important difference for the St George's Respiratory Questionnaire in patients with severe COPD. Eur Respir J 2015; 46: 1598-1604.
58. Schultz, K et al. Inspiratory Muscle Training does not improve clinical outcomes in 3-week COPD rehabilitation: Results from a Randomised Controlled Trial. European Respiratory Journal 2018; 51: 1702000.
59. Alma, HJ et al. Thresholds for clinically important deterioration versus improvement in COPD health status: results from a randomised controlled trial in pulmonary rehabilitation and an observational study during routine clinical practice. BMJ Open 2019; 0: e025776. Doi:10.1136/bmjopen-2018-025776.
60. Jones, PW et al. Development and first validation of the COPD Assessment Test. Eur Respir J 2009; 34: 648-654.
61. Van der Molen, T et al. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes 2003; 1: 13.
62. Jones, PW, Quirk, FH and Baveystock, CM. The St George's Respiratory Questionnaire. Respir Med 1991; 85: 25-31.
63. Juniper, EF et al. Determining a minimal important change in a disease-specific quality of life questionnaire. J Clin Epidemiol 1994; 47 (1): 81-87.
64. de Vet, HC, Terwee, CB, Mokkink, LB and Knol, DL. Measurement in medicine: a practical guide. Cambridge University Press, 2011.
65. Norman, GR, Sloan, JA and Wyrwich, KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003; 41: 582-592.
66. Terwee, CB et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 2007; 60: 34-42.
67. Benjamini, Y and Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society B 1995; 57: 289-300.
68. Revicki, D et al. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol 2008; 61: 102-109.
69. Rouquette, A et al. The minimal clinically important difference determined using item response theory models: an attempt to solve the issue of the association with baseline score. J Clin Epidemiol 2014; 67 (4): 433-440.
70. Zhang, Y et al. Although not consistently superior, the absolute approach to framing the minimally important difference has advantages over the relative approach. J of Clin Epidemiol 2015; 2015.
71. Yuksel, S et al. Minimum Clinically Important Difference of the Health-Related Quality of Life Scales in Adult Spinal Deformity Calculated by Latent Class Analysis: Is It Appropriate to Use the Same Values for Surgical and Non-Surgical Patients? The Spine Journal 2018; Epub ahead of print.
72. Nicolini, A et al. Gender differences in chronic obstructive pulmonary diseases: a narrative review. Panminerva Med 2018; Epub ahead of print.
73. Martinez, CH et al. Age-Related Differences in Health-Related Quality of Life in COPD. Chest 2016; 149(4): 927-935.
74. Corlateanu, A et al. Prevalence and burden of comorbidities in Chronic Obstructive Pulmonary Disease. Respiratory Investigation 2016; 54: 387-396.
75. Ousmen, A et al. Impact of the occurrence of a response shift on the determination of the minimal important difference in a health-related quality of life score over time. Health Qual Life Outcomes 2016; 14: 167.